Stonegate Capital Partners Updates Coverage on Burcon Nutrascience Corporation (BU) FY26 Q2

Newsfile Corp.
2025.11.13 13:48
portai
I'm PortAI, I can summarize articles.

Stonegate Capital Partners has updated its coverage on Burcon Nutrascience Corporation for FY26 Q2. Burcon achieved first commercial production and sales of Puratein® C canola protein and FavaPro fava protein, and scaled Peazazz® C pea protein. The company generated $0.36M in revenues, a 783% increase from the previous year, and received over $500,000 in commercial sales orders. Financing was strengthened by $4.0M in unsecured convertible debentures and a $0.7M short-term loan.